Clin2
NCT07611708Possibly a fitNot yet recruiting

Lubricin-inspired Treatment for Knee Osteoarthritis Pain

Osteo Arthritis of the Knee

Part of Bones, joints & muscles, Pain clinical trials.

This trial tests a new lubricin-inspired treatment designed to help people with moderate to severe knee osteoarthritis who haven't gotten enough pain relief from standard treatments like NSAIDs or physical therapy. The study aims to see if this approach can reduce knee pain and improve function.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
25 people
Ages
40 years and older
Study type
Interventional

Who can take part

  • Age 40 or older
  • Knee osteoarthritis confirmed on X-ray (grades 2–4 severity)
  • Moderate to severe knee pain (at least 15 days per month) that hasn't improved enough with first-line treatments like NSAIDs or physical therapy
  • Willing to keep your current pain medications stable throughout the trial and stop taking 'as needed' pain pills (except rescue medication)
  • No knee surgery or steroid injections in your target knee within the past 6 months, and no surgery planned in the next 8 months
  • Able to understand study instructions and attend scheduled clinic visits

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07226258Recruiting· Phase 3
Testing SL1002 for knee pain caused by osteoarthritis

This trial tests a study drug called SL1002 to see if it reduces knee pain from osteoarthritis. It may be an option for people with chronic knee pain who haven't found enough relief from current treatments.

Roseville, California
NCT07203547Not yet recruiting· Phase 4
Study of Laybon Tab. for knee osteoarthritis pain

This trial tests whether Laybon Tab. helps reduce knee pain in people with knee osteoarthritis. It is for adults aged 40 to 80 who have had knee pain for at least 3 months and are ready to stop other pain treatments during the study.

NCT06343714Recruiting· Phase 1
Testing a new drug for knee osteoarthritis pain

This study tests a new antibody drug (FB1003) for people with knee osteoarthritis pain. It will check if the drug is safe and helps reduce pain. You may be eligible if you have moderate to severe knee pain and are willing to temporarily stop your usual pain medications.

Brisbane, Queensland
NCT07641517Recruiting· Phase 2
Testing LY4065967 for chronic knee osteoarthritis pain

This study tests an experimental drug called LY4065967 to see if it can help reduce pain from osteoarthritis in the knee. You'll be in the trial for several months, with regular check-ins and pain assessments.

Birmingham, Alabama
NCT07178951Recruiting
Ultrasound-guided nerve treatment for knee osteoarthritis pain

This trial tests a non-surgical treatment that uses ultrasound to target nerves causing pain on the inner side of your knee due to osteoarthritis. It may help reduce pain and improve function for people with moderate to severe knee pain.

North York, Ontario
NCT06245109Recruiting· Phase 4
Pain medicine study for knee osteoarthritis

This study tests how well different pain medicines work for knee osteoarthritis and looks at brain patterns to understand why some people get more relief. It may help you find a treatment that works best for you.

Chicago, Illinois

Hear when a new Osteo Arthritis of the Knee trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.